nach oben

Current Treatment Options in Gastroenterology

Erschienen in:

22.02.2023 | Esophagus (K Ravi, Section Editor)

Management of Non-achalasia Esophageal Hypercontractility: EGJ Outflow Obstruction and Hypercontractile Esophagus

verfasst von: Farnoosh Vahedi, MD, Eric E. Low, MD, MPH, Rena Yadlapati, MD, MS

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

We review and summarize current evidence-based management strategies for non-achalasia esophageal hypercontractility disorders: esophagogastric junction outflow obstruction (EGJOO) and hypercontractile esophagus.

Recent findings

EGJOO. Per Chicago Classifications version 4.0 (CCv4.0), current diagnostic criteria for EGJOO require conclusive manometric findings, clinically relevant symptoms plus at least one supportive test confirming obstruction (either timed barium esophagram (TBE) or functional lumen imaging probe (FLIP)). Hypercontractile esophagus. Per CCv4.0, current diagnostic criteria for hypercontractile esophagus requires conclusive manometric findings in addition to clinically relevant symptoms. Three identifiable sub-groups of hypercontractile esophagus include single-peak hypercontractility, Jackhammer esophagus, and hypercontractile with LES after-contraction.

Summary

Updates in CCv4.0 focus on distinguishing clinically relevant esophageal disorders from manometric patterns alone. As definitive therapies for esophageal disorders are limited, current approaches to treatment focus on achieving symptom relief with conservative modalities prior to attempting more invasive therapies.

Verma A, Misra A, Ghoshal UC. High-resolution esophageal manometry: principles, technique, and interpretation. In: Ghoshal UC, editor. Evaluation of gastrointestinal motility and its disorders. New Delhi: Springer India; 2016. p. 11–22.CrossRef

Dodds WJ, Stef JJ, Hogan WJ. Factors determining pressure measurement accuracy by intraluminal esophageal manometry. Gastroenterology. 1976;70(1):117–23.CrossRefPubMed

Arndorfer RC, Stef JJ, Dodds WJ, Linehan JH, Hogan WJ. Improved infusion system for intraluminal esophageal manometry. Gastroenterology. 1977;73(1):23–7.CrossRefPubMed

Pandolfino JE, Kwiatek MA, Nealis T, Bulsiewicz W, Post J, Kahrilas PJ. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135(5):1526–33. https://doi.org/10.1053/j.gastro.2008.07.022.CrossRefPubMed

Gyawali CP, Kahrilas PJ. A short history of high-resolution esophageal manometry. Dysphagia. 2021. https://doi.org/10.1007/s00455-021-10372-7.CrossRefPubMed

Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society. 2015;27(2):160–74. https://doi.org/10.1111/nmo.12477.

7.••

Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(©). Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society. 2021;33(1):e14058. https://doi.org/10.1111/nmo.14058. Most recent classification scheme for esophageal motility disorders using metrics from high-resolution manometry from the international working group of fifty-two experts in the field.

Yadlapati R, Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. What is new in Chicago Classification version 4.0? Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2021;33(1):e14053. https://doi.org/10.1111/nmo.14053.CrossRef

Low EE, Yadlapati R. Editorial: reducing false alarms with oesophagogastric junction outflow obstruction. Aliment Pharmacol Ther. 2022;56(5):890–1. https://doi.org/10.1111/apt.17131.CrossRefPubMed

10.•

Visaggi P, Ghisa M, Del Corso G, Baiano Svizzero F, Mariani L, Tolone S, et al. Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction. Aliment Pharmacol Ther. 2022;56(4):606–13. https://doi.org/10.1111/apt.17101. Recent study on the role on integrated relaxation pressure during rapid drink challenge for diagnosis of EGJOO.

11.

Zikos TA, Triadafilopoulos G, Clarke JO. Esophagogastric junction outflow obstruction: current approach to diagnosis and management. Curr Gastroenterol Rep. 2020;22(2):9. https://doi.org/10.1007/s11894-020-0743-0.CrossRefPubMed

12.

Samo S, Qayed E. Esophagogastric junction outflow obstruction: where are we now in diagnosis and management? World J Gastroenterol. 2019;25(4):411–7. https://doi.org/10.3748/wjg.v25.i4.411.CrossRefPubMedPubMedCentral

13.

Babaei A, Szabo A, Shad S, Massey BT. Chronic daily opioid exposure is associated with dysphagia, esophageal outflow obstruction, and disordered peristalsis. Neurogastroenterol Motilit: Off J Eur Gastrointest Motil Soc. 2019;31(7):e13601. https://doi.org/10.1111/nmo.13601.CrossRef

14.•

Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110(7):979–84. https://doi.org/10.1038/ajg.2015.154. Retrospective study investigating the role of chronic opioids on esophageal motor disorders.

15.

Sanchez MJ, Olivier S, Gediklioglu F, Almeida M, Gaeta M, Nigro M, et al. Chronic opioid use is associated with obstructive and spastic disorders in the esophagus. Neurogastroenterol Motilit: Off J Eur Gastrointest Motil Soc. 2022;34(3):e14233. https://doi.org/10.1111/nmo.14233.CrossRef

16.

Schupack D, Katzka DA, Geno DM, Ravi K. The clinical significance of esophagogastric junction outflow obstruction and hypercontractile esophagus in high resolution esophageal manometry. Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2017;29(10):1–9. https://doi.org/10.1111/nmo.13105.CrossRef

17.

Carlson DA, Yadlapati R, Pandolfino JE. AJG red section: the tailored approach to manometric esophagogastric junction outflow obstruction (EGJOO): treat the clinical diagnosis, not the manometry pattern. Off J Am Coll Gastroenterol| ACG. 9900: https://doi.org/10.14309/ajg.0000000000001938.

18.

Bredenoord AJ, Babaei A, Carlson D, Omari T, Akiyama J, Yadlapati R, et al. Esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2021;33(9):e14193. https://doi.org/10.1111/nmo.14193.CrossRefPubMed

19.

Pérez-Fernández MT, Santander C, Marinero A, Burgos-Santamaría D, Chavarría-Herbozo C. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2016;28(1):116–26. https://doi.org/10.1111/nmo.12708.CrossRef

20.

Kraichely RE, Arora AS, Murray JA. Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther. 2010;31(5):601–6. https://doi.org/10.1111/j.1365-2036.2009.04212.x.CrossRefPubMed

21.

Sadiq NM, Dice TJ, Mead T. Oxycodone. [Updated 2022 Aug 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK482226/

22.

J Rajan, FRCA, J Scott-Warren, DRCOG MRCP FRCA FFPMRCA, The clinical use of methadone in cancer and chronic pain medicine, BJA Ed. 2016;16(3):102–106.

23.

Maradey-Romero C, Gabbard S, Fass R. Treatment of esophageal motility disorders based on the chicago classification. Curr Treat Options Gastroenterol. 2014;12(4):441–55. https://doi.org/10.1007/s11938-014-0032-9.CrossRefPubMed

24.

Beveridge C, Lynch K. Diagnosis and management of esophagogastric junction outflow obstruction. Gastroenterol Hep. 2020;16(3):131–8.

25.

van Hoeij FB, Tack JF, Pandolfino JE, Sternbach JM, Roman S, Smout AJ, et al. Complications of botulinum toxin injections for treatment of esophageal motility disorders†. Dis Esophagus: Off J Int Soc Dis Esophagus. 2017;30(3):1–5. https://doi.org/10.1111/dote.12491.CrossRef

26.

Beveridge CA, Triggs JR, Thanawala SU, Ahuja NK, Falk GW, Benitez AJ, et al. Can FLIP guide therapy in idiopathic esophagogastric junction outflow obstruction? Dis Esophagus: Off J Int Soc Dis Esophagus. 2022;35(4). https://doi.org/10.1093/dote/doab077.

27.

Ribolsi M, Ghisa M, Savarino E. Nonachalasic esophageal motor disorders, from diagnosis to therapy. Expert Rev Gastroenterol Hepatol. 2022;16(3):205–16. https://doi.org/10.1080/17474124.2022.2047648.CrossRefPubMed

28.•

Clayton SB, Shin CM, Ewing A, Blonski W, Richter J. Pneumatic dilation improves esophageal emptying and symptoms in patients with idiopathic esophago-gastric junction outflow obstruction. Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2019;31(3):e13522. https://doi.org/10.1111/nmo.13522. Study looking at the utility of PD in treatment of EGJOO.CrossRef

29.

Lynch KL, Pandolfino JE, Howden CW, Kahrilas PJ. Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol. 2012;107(12):1817–25. https://doi.org/10.1038/ajg.2012.332.CrossRefPubMed

30.

Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M, Cuttitta A, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. New England J Med. 2011;364(19):1807–16. https://doi.org/10.1056/NEJMoa1010502.CrossRef

31.

Khashab MA, Familiari P, Draganov PV, Aridi HD, Cho JY, Ujiki M, et al. Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study. Endosc Int Open. 2018;6(8):E1031–6. https://doi.org/10.1055/a-0625-6288.CrossRefPubMedPubMedCentral

32.

Haito-Chavez Y, Inoue H, Beard KW, Draganov PV, Ujiki M, Rahden BHA, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol. 2017;112(8):1267–76. https://doi.org/10.1038/ajg.2017.139.CrossRefPubMed

33.

Salvador R, Provenzano L, Nezi G, Capovilla G, Nicoletti L, Pierobon ES, et al. Laparoscopic Heller-Dor is an effective treatment for esophageal-gastric junction outflow obstruction. J Gastrointest Surg:Off J Soc Surg Aliment Tract. 2021;25(9):2201–7. https://doi.org/10.1007/s11605-021-05021-1.CrossRef

34.

Schlottmann F, Luckett DJ, Fine J, Shaheen NJ, Patti MG. Laparoscopic Heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg. 2018;267(3):451–60.CrossRefPubMed

35.

Hasan A, Low EE, Fehmi SA, Yadlapati R. Evolution and evidence-based adaptations in techniques for peroral endoscopic myotomy for achalasia. Gastrointest Endosc. 2022;96(2):189–96.CrossRefPubMedPubMedCentral

36.

Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M, et al. Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors. Sci Rep. 2018;8(1):9949. https://doi.org/10.1038/s41598-018-27756-9.CrossRefPubMedPubMedCentral

37.

Clément M, Zhu WJ, Neshkova E, Bouin M. Jackhammer esophagus: from manometric diagnosis to clinical presentation. Can J Gastroenterol Hepatol. 2019;2019:5036160. https://doi.org/10.1155/2019/5036160.CrossRefPubMedPubMedCentral

38.

Wahba G, Bouin M. Jackhammer esophagus: a meta-analysis of patient demographics, disease presentation, high-resolution manometry data, and treatment outcomes. Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2020;32(11):e13870. https://doi.org/10.1111/nmo.13870.CrossRef

39.

Savarino E, Smout A. The hypercontractile esophagus: still a tough nut to crack. Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2020;32(11):e14010. https://doi.org/10.1111/nmo.14010.CrossRef

40.

de Bortoli N, Gyawali PC, Roman S, Tolone S, Sifrim D, Tutuian R, et al. Hypercontractile esophagus from pathophysiology to management: proceedings of the Pisa symposium. Am J Gastroenterol. 2021;116(2):263–73. https://doi.org/10.14309/ajg.0000000000001061.CrossRefPubMed

41.

Al-Qaisi MT, Siddiki HA, Crowell MD, Burdick GE, Fleischer DE, Ramirez FC, et al. The clinical significance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with Jackhammer esophagus versus Nutcracker esophagus. Dis Esophagus: Off J Int Soc Dis Esophagus. 2017;30(12):1–7. https://doi.org/10.1093/dote/dox085.CrossRef

42.

Chen JW, Savarino E, Smout A, Xiao Y, de Bortoli N, Yadlapati R, et al. Chicago Classification update (v4.0): technical review on diagnostic criteria for hypercontractile esophagus. Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2021;33(6):e14115. https://doi.org/10.1111/nmo.14115.CrossRef

43.

Ravi K, Friesen L, Issaka R, Kahrilas PJ, Pandolfino JE. Long-term outcomes of patients with normal or minor motor function abnormalities detected by high-resolution esophageal manometry. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2015;13(8):1416–23. https://doi.org/10.1016/j.cgh.2015.02.046.CrossRef

44.

Patel DA, Yadlapati R, Vaezi MF. Esophageal motility disorders: current approach to diagnostics and therapeutics. Gastroenterology. 2022;162(6):1617–34. https://doi.org/10.1053/j.gastro.2021.12.289.CrossRefPubMed

45.

Vanuytsel T, Bisschops R, Farré R, Pauwels A, Holvoet L, Arts J, et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11(9):1115-21.e2. https://doi.org/10.1016/j.cgh.2013.03.021.CrossRefPubMed

46.

Miller LS, Pullela SV, Parkman HP, Schiano TD, Cassidy MJ, Cohen S, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol. 2002;97(7):1640–6. https://doi.org/10.1016/S0002-9270(02)04177-1.CrossRefPubMed

47.

Khan MA, Kumbhari V, Ngamruengphong S, Ismail A, Chen YI, Chavez YH, et al. Is POEM the answer for management of spastic esophageal disorders? A systematic review and meta-analysis. Dig Dis Sci. 2017;62(1):35–44. https://doi.org/10.1007/s10620-016-4373-1.CrossRefPubMed

Titel: Management of Non-achalasia Esophageal Hypercontractility: EGJ Outflow Obstruction and Hypercontractile Esophagus
verfasst von: Farnoosh Vahedi, MD
Eric E. Low, MD, MPH
Rena Yadlapati, MD, MS
Publikationsdatum: 22.02.2023
Verlag: Springer US
Erschienen in: Current Treatment Options in Gastroenterology / Ausgabe 1/2023
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI: https://doi.org/10.1007/s11938-023-00410-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Management of Non-achalasia Esophageal Hypercontractility: EGJ Outflow Obstruction and Hypercontractile Esophagus

Abstract

Purpose of review

Recent findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Purpose of review

Recent findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Autoimmune Gastritis: Update and New Perspectives in Therapeutic Management

Management of Esophageal Diverticula

Obesity Pharmacotherapy: a Review of Current Practices and Future Directions

A Review of Complications, Outcomes, and Technical Considerations of Endoscopically Placed Feeding Tubes in Obesity

The Role of the Gastroenterologist in Modern Nutrition Support Services

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Update Innere Medizin